BioSpace News Archive

Collaboratively Developed Technologies Support Patient-Centric Care By Allowing Nurses to Spend More Time at the Bedside

DiamiR announced that it will exhibit at the Alzheimer’s Association International Conference to be held in Chicago, IL on July 22-26, 2018.

Wet-absorptive microsampling first to be used in home-sampling environment

Michael Haritakis joins both organizations as entrepreneur-in-residence

July 19, 2018 12:00 UTC Ocular Therapeutix™ Announces FDA Acceptance of NDA Resubmission for DEXTENZA® PDUFA date is set for December 28, 2018 BEDFORD, Mass.--( BUSINESS WIRE )-- Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it has received acknowle

Key endpoints in all-six subjects — no hemolysis, no thrombosis at low anticoagulation and no functional device wear — will be used for CE mark registration and FDA submission of Mobybox™, the initial application of Hemovent’s Bionique™ platform.

Trevi Therapeutics, Inc. announced that it has named Yann Mazabraud as its Chief Commercial Officer and Head of International

Plexus Technology Group, LLC is pleased to announce they are working with Interface People (IPeople) to offer a discrete controlled-substance reconciliation feature that is available to all Plexus TG clients.

RxBenefit Clarity™ Expands Reach to EHRs and Epic Health Systems Throughout the Nation

Creative Medical Technology Holdings Inc. announced that its subsidiary Caverstem International LLC has signed an exclusive contract with Promo Med Russia for the commercialization of its CaverStemTM technology.